Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Aerowash
Active Ingredient: Sodium chloride 0.135g
Dosage Form: Eye irrigation
New Zealand Sponsor: Amtech Medical Limited
Manufacturer: Demo SA Pharmaceutical Industry, Athens, Greece
Product: Ilaris
Active Ingredient: Canakinumab 150mg
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Thymoglobuline
Active Ingredient: Antithymocyte immunoglobulin 25mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Genzyme Polyclonals SAS, Marcy L’Etoile, France
Dated this 21st day of April 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).